A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Clinical trial NCT04370587 · RECRUITING

Trial details

NCT number: NCT04370587
Sponsor: ImmVira Pharma Co. Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Melanoma HNSCC Sarcoma Squamous Cell Carcinoma NSCLC

Start date: 2020-09-17
Primary completion: 2026-09-22
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.